Analysis | Paracetamol | Control | OR (95% CI) | Metoclopramide | Control | OR (95% CI) | Ceftriaxone | Control | OR (95% CI) | |
---|---|---|---|---|---|---|---|---|---|---|
mRS, median | ||||||||||
Ischaemic stroke | aOLR | Median [IQR] | Median [IQR] | aOR (95% CI) | Median [IQR] | Median [IQR] | aOR (95% CI) | Median [IQR] | Median [IQR] | aOR (95% CI) |
Intracerebral haemorrhage | aOLR | Median [IQR] | Median [IQR] | aOR (95% CI) | Median [IQR] | Median [IQR] | aOR (95% CI) | Median [IQR] | Median [IQR] | aOR (95% CI) |
Other diagnosis | aOLR | Median [IQR] | Median [IQR] | aOR (95% CI) | Median [IQR] | Median [IQR] | aOR (95% CI) | Median [IQR] | Median [IQR] | aOR (95% CI) |
Mortality | aCPHR | n (%) | n (%) | aHR (95% CI) | n (%) | n (%) | aHR (95% CI) | n (%) | n (%) | aHR (95% CI) |
mRS, unfavourable outcome | aBLR | n (%) | n (%) | aOR (95% CI) | n (%) | n (%) | aOR (95% CI) | n (%) | n (%) | aOR (95% CI) |
Patient location | aOLR | aOR (95% CI) | aOR (95% CI) | aOR (95% CI) | ||||||
Hospital | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||||
Rehabilitation service | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||||
Nursing home | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||||
Home | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||||
Home time (no. of days) | aMLR | Mean (SD) | Mean (SD) | aDIM (95% CI) | Mean (SD) | Mean (SD) | aDIM (95% CI) | Mean (SD) | Mean (SD) | aDIM (95% CI) |
Questionnaires | ||||||||||
Barthel Index | aMLR | Mean (SD) | Mean (SD) | aDIM (95% CI) | Mean (SD) | Mean (SD) | aDIM (95% CI) | Mean (SD) | Mean (SD) | aDIM (95% CI) |
MoCA | aMLR | Mean (SD) | Mean (SD) | aDIM (95% CI) | Mean (SD) | Mean (SD) | aDIM (95% CI) | Mean (SD) | Mean (SD) | aDIM (95% CI) |
EQ-5D-5L | aMLR | Mean (SD) | Mean (SD) | aDIM (95% CI) | Mean (SD) | Mean (SD) | aDIM (95% CI) | Mean (SD) | Mean (SD) | aDIM (95% CI) |
EQ-VAS | aMLR | Mean (SD) | Mean (SD) | aDIM (95% CI) | Mean (SD) | Mean (SD) | aDIM (95% CI) | Mean (SD) | Mean (SD) | aDIM (95% CI) |